Carbitocin for reducing blood loss in fibroid surgery
Treatments studied
Part of Blood & lymphatic, Women’s health & pregnancy clinical trials.
This trial tests if carbitocin, a drug that helps the uterus contract, can reduce bleeding during open surgery to remove uterine fibroids (myomectomy).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for open abdominal surgery to remove fibroids (not vaginal or laparoscopic).
- You are not allergic to carbitocin or similar drugs.
- You do not have a history of blood clots, bleeding disorders, kidney or liver disease, or chronic anemia.
- You have not had fibroid treatment like embolization or hormone therapy before surgery.
- Your fibroids are in the muscle of the uterus, not outside or in other tissues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two medication approaches to prevent excessive bleeding during planned cesarean delivery under spinal anesthesia. Researchers want to see if one medication (carbetocin) works as well as carbetocin combined with a second medication (oxytocin).
This trial compares two injected medicines (terlipressin vs carbetocin) given into the uterus during open fibroid (myomectomy) surgery to see which one reduces blood loss and helps maintain hemoglobin. It may help patients by targeting lower bleeding during surgery.
This trial compares two medications (ergometrine and carbetocin) given during surgery to see which one is better at reducing bleeding while removing fibroids. Both drugs help the uterus contract to control blood loss.
This study compares two different medications given as shots during laparoscopic fibroid (myomectomy) surgery. The goal is to see which shot better reduces blood loss and helps keep hemoglobin (a blood oxygen-carrying protein) from dropping too much.
This trial compares two surgical techniques to reduce bleeding during surgery to remove fibroids (benign tumors) from the uterus. The goal is to find the safest, least-bloody approach for women who need this procedure.
This trial tests whether temporarily clamping the main blood vessels to the uterus during laparoscopic fibroid removal can reduce blood loss. It is for women with up to four fibroids who are planning this type of surgery.
Hear when a new Blood Loss, Surgical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.